CASE STUDY | MEDICAL COMMUNICATIONS
When Oncology Data Needed Direction, We Turned Insight into Action.
THE CHALLENGE
Translating New Oncology Data into Actionable Medical Strategy
Following the availability of new follow-up data for an oncology treatment, a top pharmaceutical company needed to understand the clinical impact of these findings and how they would influence treatment decisions and clinical practice.
The company required a structured approach to generate meaningful insights for their Medical Affairs team and to translate them into a clear direction for Medical Affairs strategy and Field Medical execution.
THE BREAKTHROUGH
Designing a Structured Advisory Board Model to Generate Actionable Oncology Insights
BGBx recognized that generating meaningful insights required more than convening an advisory board. It required a structured approach to ensure discussions were focused, data-driven, and aligned to key clinical questions.
Through our proprietary Breakthrough Process, powered by 3D Science, BGBx Medical Affairs experts designed a comprehensive engagement model spanning pre-meeting planning, meeting execution, and post-meeting synthesis.
The approach integrated:
- Pre-meeting surveys to establish baseline clinical practice patterns and decision-making factors
- Focused agendas and supporting stimuli, including clinical data, landscape analysis, and target patient candidates
- Moderated discussions guided by survey findings and structured questions
- Interactive polling and breakout workshops to elicit balanced perspectives
- Post-meeting debriefs and executive summaries to translate discussion into actionable insights
This structured approach ensured insight generation remained focused, purposeful, and directly tied to clinical decision-making.
THE RESULTS
Actionable Oncology Insights Strengthened Medical Strategy and Field Execution
The advisory board generated actionable insights that clarified the most clinically impactful data and supported its elevation within the scientific narrative.
These insights informed updates to Medical Affairs strategy and Field Medical tactics, including proactive field tools, infographics, and medical engagement initiatives. They also informed additional data generation priorities as part of evidence planning.
Actionable
Oncology Insights
Generated for Medical Affairs
Field Medical
Execution
Materials and tactics informed
Evidence
Planning
Data priorities supported
Our Perspectives on Advertising
2026 Oncology Market Access Trends
Implications of the IRA’s Maximum Fair Price (MFP) Negotiations
340B Drug Discount Program
Turn Clinical Discussion into Actionable Medical Insight
At BGBx, we design advisory boards that transform clinical discussion into focused, actionable Medical Affairs insights, ensuring your strategy is grounded in real-world clinical perspectives.
